Please login to the form below

Not currently logged in
Email:
Password:

Workers at Janssen strike over job cuts

Employees at US-based pharmaceutical company Johnson & Johnson's Belgian research subsidiary Janssen Pharmaceutica have gone on strike.

Employees at US-based pharmaceutical company Johnson & Johnson's (J&J) Belgian research subsidiary Janssen Pharmaceutica have gone on strike.

J&J revealed back in July 2007 that it would cut between three and four per cent of its global workforce (up to 4,800 jobs) to offset declining sales of drugs due to generic competition and upcoming loss of patent protection.

As a result, Janssen Pharmaceutica said it would cut costs by 15 per cent, including the loss of 521 full-time employees, while not renewing 167 temporary worker contracts.

On 15 November, a social plan presented to Janssen workers was rejected by 90 per cent of employees. The strike was called on 19 November.

According to Janssen's head of public affairs Stefan Gijssels, three Janssen plants are affected. Nearly all of the 4,700-strong work force are joining in the industrial action, and just a few clinical trials are still active.

Gijssels added: "This affects all our activities. We have no idea how long it will last, but we have to talk with unions as soon as possible. That means probably in the coming days. At the same time we have to invest in research. We are in the same boat as a number of other pharmaceutical companies."

30th September 2008

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...

Infographics